Loading people...
Kristin Baker Spohn is a General Partner at CRV based in San Francisco, California, where she leads early-stage investments in the enterprise and healthcare technology sectors. Before joining CRV in 2019, she served as a Partner at Social Capital and held executive operating roles, including Chief Commercial Officer at Collective Health and Vice President of Product at Castlight Health. Her venture capital portfolio features several notable transactions, such as leading a $50 million Series B funding round for Viz.ai and directing a $22 million Series A investment in Little Otter in 2022. She also secured a board seat at Waitwhile following a $12 million Series A round in 2021, and she holds degrees from Stanford University and Harvard University. Spohn leverages her extensive operational background to identify and scale software startups navigating complex healthcare ecosystems.
Kristin Baker Spohn is a distinguished General Partner at CRV, a leading venture capital firm known for backing transformative technology companies. At CRV, Kristin plays a pivotal role in identifying and nurturing early-stage startups, primarily concentrating her investments in the dynamic healthcare and enterprise technology landscapes. Her investment thesis is centered on supporting founders who are building innovative solutions that address critical needs and drive significant market disruption.
Within healthcare, Kristin's focus areas are broad yet strategic, encompassing digital health, health tech, biotech services, diagnostics, and life sciences tools. She is particularly interested in companies that leverage technology to improve patient outcomes, enhance provider efficiency, and create more accessible and affordable healthcare systems. Beyond healthcare, she also actively invests in enterprise software and SaaS companies that offer compelling value propositions and robust growth potential.
Kristin's journey into venture capital is underpinned by a strong foundation as a successful healthcare entrepreneur. Prior to joining CRV, she founded and served as CEO of Curtsy, a company focused on improving healthcare access, which was later acquired by Healthgrades. Her entrepreneurial spirit and operational acumen were also honed during her time as a founding team member and Vice President of Product at Castlight Health, a pioneering company in healthcare transparency. Earlier in her career, Kristin gained valuable strategic experience as a consultant at McKinsey & Company, advising clients across various industries. She holds an MBA from Stanford University and a BA from Harvard University, providing her with a robust academic background that complements her extensive practical experience.
Her portfolio at CRV includes several notable investments that highlight her commitment to backing innovative companies. These include Wheel, a platform for virtual care infrastructure; Vivante Health, focused on digestive health solutions; Nabla, an AI assistant for healthcare providers; Reify Health, a clinical trial software company; and Spring Health, a comprehensive mental health benefits provider. Through these investments, Kristin Baker Spohn demonstrates her dedication to fostering the next generation of market leaders in healthcare and enterprise technology, guiding them from early concept to significant market impact.
Kristin Baker Spohn is a General Partner at CRV, a prominent venture capital firm. She is an experienced investor and former healthcare entrepreneur, known for her focus on early-stage technology companies.
Kristin Baker Spohn primarily invests in early-stage companies within the healthcare and enterprise technology sectors. Her healthcare focus includes digital health, health tech, biotech services, diagnostics, and life sciences tools, while her enterprise focus includes innovative software and SaaS solutions.
Kristin Baker Spohn works as a General Partner at CRV, a leading venture capital firm that invests in early-stage technology companies across various industries.
